Literature DB >> 602938

Coagulopathy in amyloidosis: combined deficiency of factors IX and X.

R A McPherson, J W Onstad, R J Ugoretz, P L Wolf.   

Abstract

Combined severe deficiencies of blood clotting factors IX and X were observed in 2 patients who suffered from systemic amyloidosis. This unique deficiency state was marked by refractoriness to Vitamin K as well as to transfusion therapy. Increased antithrombin activity was present in both individuals and corresponded in time to the emergence of a monoclonal IgG kappa light chain paraprotein in 1. Both patients demonstrated profound bleeding disorders. It is hypothesized that the Vitamin K dependent factors have special affinity for amyloid deposits due to an unusual amino acid (gamma-carboxyglutamic acid) present in these factors.

Entities:  

Mesh:

Year:  1977        PMID: 602938     DOI: 10.1002/ajh.2830030303

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Naturally occurring canine nephrotic syndrome is a potentially hypercoagulable state.

Authors:  A Rasedee; B F Feldman; R Washabau
Journal:  Acta Vet Scand       Date:  1986       Impact factor: 1.695

Review 2.  Hemostatic changes in patients with malignancy.

Authors:  G H Goldsmith
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  Reversible functional asplenia and subcapsular liver hematoma--two distinctive manifestations of amyloidosis.

Authors:  E Levy-Lahad; D Steiner-Salz; N Berkman; R Chisin; P Levensart; E Leitersdorf
Journal:  Klin Wochenschr       Date:  1987-11-16

Review 4.  Amyloidosis associated bleeding diatheses in the surgical patient.

Authors:  A R Mizutani; C F Ward
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

5.  Factor X deficiency: an uncommon presentation of AL amyloidosis.

Authors:  Ajaydas T Manikkan
Journal:  Ups J Med Sci       Date:  2012-06-01       Impact factor: 2.384

6.  Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.

Authors:  Yong-Mei Guo; Nagi Takahashi; Ken Miyabe; Makoto Yoshida; Fumito Abe; Takaya Yamashita; Miho Nara; Tomoko Yoshioka; Kenichi Ohashi; Akiteru Goto; Naoto Takahashi
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

7.  [Primary light chain amyloidosis onset with acquired FX deficiency: a case report and literature review].

Authors:  C Wei; J Feng; T N Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

Review 8.  Multidisciplinary supportive care in systemic light chain amyloidosis.

Authors:  Bou Zerdan Maroun; Sabine Allam; Chakra P Chaulagain
Journal:  Blood Res       Date:  2022-05-20

9.  Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.

Authors:  Pradeep K Singh; Zu-Lin Chen; Katharina Horn; Erin H Norris
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13

10.  A Rare Cause of Coagulopathy in a Patient with Rapidly Progressive Renal Failure.

Authors:  Rudreshwar Prabakaran; Jasmine Sethi; Manish Rathi; Harbir Singh Kohli; Pankaj Malhotra; Krishan Lal Gupta
Journal:  Indian J Nephrol       Date:  2020-02-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.